Melissa Gaines

Role: Senior Vice President, Clinical Operations at Annovis Bio, Inc
Location: Philadelphia, PA, US
LinkedIn followers: 500 followers

OperationsView LinkedIn profile

Experience

Senior Vice President, Clinical Operations
Annovis Bio, Inc
Aug 2023 — Present

Skills

Pharmaceutical Industry
CRO Management
CRO
Ich-Gcp
Infectious Diseases
Data Management
Neurology
Patient Recruitment
Clinical Data Management
Oncology
Drug Development
Good Clinical Practice (Gcp)
Regulatory Submissions
Clinical Trials
Clinical Development
Clinical Research
Clinical Operations
Phase I
Pharmacovigilance
Psychiatry
Sop
Edc
Electronic Data Capture (Edc)
Ctms
Clinical Trial Management System (Ctms)
Gcp
Protocol
Therapeutic Areas
Neuroscience
Clinical Monitoring

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@annovisbio.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Annovis Bio, Inc

Biotechnology Research · 12 employees · Founded 2008 · Malvern, Pennsylvania, United States

Annovis Bio (NYSE: ANVS) is a Phase 3 clinical-stage biotechnology company pioneering a new paradigm for treating chronic and acute neurodegenerative diseases — addressing one of the greatest unmet needs of our aging population: Alzheimer’s disease (AD) and Parkinson’s disease (PD). Our pipeline extends to other conditions driven by toxic protein accumulation, including traumatic brain injury (TBI), stroke, Down syndrome, Huntington’s disease, and certain neuropsychiatric disorders. Our lead investigational oral therapy, buntanetap, is a safe, once-daily pill designed to inhibit the overproduction of multiple neurotoxic proteins — including amyloid precursor protein (APP) and amyloid beta, tau, α-synuclein, and TDP-43 — through a unique RNA-targeted translational mechanism of action. By modulating protein synthesis upstream, buntanetap is designed to address the root biological drivers of neurodegeneration. Across 13 clinical studies involving more than 1,200 participants, buntanetap has consistently demonstrated a favorable safety profile, strong tolerability, and meaningful effects on cognitive improvement. In late-stage clinical development, buntanetap significantly improved cognitive function in patients with early Alzheimer’s and early Parkinson’s disease who also showed evidence of amyloid pathology. We are currently enrolling patients in our pivotal Phase 3 clinical trial in early Alzheimer’s disease in the United States and advancing additional clinical programs aimed at transforming the treatment landscape for neurodegenerative disorders.

annovisbio.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Experience

Senior Vice President, Clinical Operations

Skills

Find verified contacts for anyone on LinkedIn